Last edition
News about "chronic heart failure"
Bayer Secures Japanese Approval for Finerenone
Bayer has received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for Finerenone (Kerendia), a non-steroidal, selective mineralocorticoid receptor antagonist, for the treatment of adult patients with chronic heart failure with mildly reduced or preserved Left Ventricular Ejection Fraction (LVEF).
Chronic Heart Failure | 23/12/2025 | By News Bureau
Dr Reddy's, Bayer to Market Second Brand of Vericiguat in India
Dr Reddy’s Laboratories has joined forces with Bayer to introduce a second brand of Vericiguat, a medication for chronic heart failure, to the Indian market.
Chronic Heart Failure | 08/04/2024 | By Aishwarya | 1226
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy